Conversion of rheumatic atrial fibrillation by amiodarone after percutaneous balloon mitral commissurotomy.
Amiodarone, used in conjunction with percutaneous balloon mitral commissurotomy, can safely convert rheumatic atrial fibrillation in 38% of patients compared with 0% in those without it. However, whether this treatment exerts long-term benefits on prognosis awaits further investigation.
Liu
Tsun-Jui
TJ
Division of Cardiology, Department of Medicine, Taichung Veterans General Hospital, Taipei, Taiwan. trliu@vghtc.vghtc.gov.tw
Hsueh
Chung-Whei
CW
Lee
Wen-Lieng
WL
Lai
Hui-Chin
HC
Wang
Kuo-Yang
KY
Ting
Chih-Tai
CT
D000638:Amiodarone / Q000009:adverse effects / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D002404:Catheterization; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000209:etiology / Q000601:surgery*; D011446:Prospective Studies; D012214:Rheumatic Heart Disease / Q000150:complications / Q000628:therapy*
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone